We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Data and Sample Collection Study to Elucidate the Mechanisms of Eosinophilic Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00267501
Recruitment Status : Recruiting
First Posted : December 21, 2005
Last Update Posted : November 13, 2015
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of this study is to elucidate the mechanisms underlying eosinophil growth, survival, migration, and function and to investigate and further characterize the pathophysiology of, clinical manifestations of, and spectrum of disease severity of eosinophilic inflammation in humans.

Condition or disease
Eosinophilic Gastrointestinal Disease Eosinophilic Inflammatory Disease Food Allergy

Study Design

Study Type : Observational
Estimated Enrollment : 5000 participants
Time Perspective: Prospective
Official Title: Eosinophils and Inflammation, an Expanded Study
Study Start Date : May 2005
Estimated Primary Completion Date : January 2050
Estimated Study Completion Date : January 2050

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts

Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with eosinophilic disorders and patients without eosinophilic disorders to serve as normal controls

Inclusion Criteria:

  • Signed informed consent obtained from the patient or parent/guardian. Assent will be obtained from all minors 11 years of age and older.
  • Carrying a diagnosis of eosinophilic gastrointestinal disease, eosinophilic inflammatory disease, or food allergy OR family member, or normal control
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00267501

Contact: Jonathan Kuhl, BS 513-803-3078 jonathan.kuhl@cchmc.org

United States, Ohio
Cincinnati Children's Hospital Medical Center Recruiting
Cincinnati, Ohio, United States, 45229-3039
Principal Investigator: Marc E. Rothenberg, M.D., Ph.D.         
Sponsors and Collaborators
Children's Hospital Medical Center, Cincinnati
Principal Investigator: Marc E. Rothenberg, M.D., Ph.D. Children's Hospital Medical Center, Cincinnati
More Information

Responsible Party: Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier: NCT00267501     History of Changes
Other Study ID Numbers: 04-12-8
R01 DK075401
First Posted: December 21, 2005    Key Record Dates
Last Update Posted: November 13, 2015
Last Verified: September 2014

Keywords provided by Children's Hospital Medical Center, Cincinnati:
Eosinophilic Disorders

Additional relevant MeSH terms:
Food Hypersensitivity
Gastrointestinal Diseases
Digestive System Diseases
Hypersensitivity, Immediate
Immune System Diseases
Leukocyte Disorders
Hematologic Diseases